Literature DB >> 8208308

Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.

T May1, A Greube, S Strauss, D Heineke, J Lehmann, H Rommelspacher.   

Abstract

The in vitro binding of the naturally occurring beta-carbolines harman and norharman in their tritium-labelled forms to cell membranes from the rat brain and liver and from bovine adrenal medulla was investigated. Displacement of the specific [3H]harman binding in bovine adrenal medulla and rat liver by several beta-carbolines and monoamine oxidase (MAO) inhibitors revealed the pharmacological profile of a single, high-affinity binding site (KD 4.92 +/- 0.43 nmol/l, Bmax 8.47 +/- 0.17 pmol/mg protein; adrenal medulla) which corresponded to the active site of MAO type A (MAO-A). Similar characteristics have previously been found for brain tissue from rat, marmoset and pig. In order to determine the temperature dependence of the [3H]harman binding, the KD and Bmax values for rat cerebral cortex were calculated from the results of saturation experiments at 5 temperatures (range: 0 degree C-37 degrees C). Whereas the Bmax values under all conditions were approximately 4 pmol/mg protein, the KD values, with increasing temperature, ranged from approximately 3 nmol/l to 30 nmol/l. The calculated linear van't Hoff plot (-ln KD against 1/T) suggested an enthalpy-driven binding of [3H]harman to MAO-A. At least three different [3H]norharman-binding sites were detected. In the rat forebrain, approximately 85% of the specific binding (at about 2 nmol/l of [3H]norharman) can be attributed to a MAO binding site of type B: the binding is displaceable, in nmol/l concentrations by the potent and selective MAO-B inhibitors MDL 72,974 A, R(-)-deprenyl and pargyline and, in mumol/l concentrations, by S(+)-deprenyl and the potent and selective MAO-A inhibitors clorgyline, harmine, harman, harmaline, brofaromine 5-F-alpha-methyltryptamine. After suppression of the MAO binding sites with 1 mumol/l clorgyline and 1 mumol/l R(-)-deprenyl, a second binding site was found. However, the binding at this site was biphasically displaceable by harman and norharman (Hill-slopes about 0.5 and 0.6, curvilinear Rosenthal plots) suggesting the presence of negative co-operativity or of two binding sites (states). A similar clorgyline/R(-)-deprenyl resistant single (Hill-slopes of displacement by norharman, harman and 6-hydroxy-beta-carboline about unity; linear Rosenthal plots) high affinity binding sites (KD 7.5 +/- 2 nmol/l, Bmax 130+/- 30 fmol/mg protein) was found in bovine adrenal medullary cell membranes. A third quite different clorgyline/R(-)-deprenyl resistant high-affinity (KD approximately 14 nmol/l) and high-density (Bmax 10-30 pmol/mg protein) binding site was detected in the liver.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8208308     DOI: 10.1007/bf00169298

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  Synthetic experiments in the group of hypotensive alkaloids. XXI.Chemistry of 1,2,3,4- tetrahydronorharmane-1-carboxylic acid and derivatives.

Authors:  Z J VEJDELEK; V TRCKA; M PROTIVA
Journal:  J Med Pharm Chem       Date:  1961-05-18

Review 2.  Thermodynamic analysis of the drug-receptor interaction.

Authors:  R B Raffa; F Porreca
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  Properties of agonist binding at the beta-adrenoceptor of the rat reticulocyte.

Authors:  G Wiemer; A Wellstein; D Palm; H M von Hattingberg; D Brockmeier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

4.  Neurotransmitter, opiate and benzodiazepine receptor binding of tetrahydroisoquinolines and beta-carbolines in brain membranes.

Authors:  Y Nimit; I Schulze; J L Cashaw; S Ruchirawat; V E Davis
Journal:  Prog Clin Biol Res       Date:  1982

Review 5.  Tetrahydroisoquinolines and beta-carbolines: putative natural substances in plants and mammals.

Authors:  H Rommelspacher; R Susilo
Journal:  Prog Drug Res       Date:  1985

Review 6.  The new generation of monoamine oxidase inhibitors.

Authors:  A M Cesura; A Pletscher
Journal:  Prog Drug Res       Date:  1992

7.  Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.

Authors:  Y Itzhak; D Mash; S H Zhang; I Stein
Journal:  Mol Pharmacol       Date:  1991-03       Impact factor: 4.436

Review 8.  Beta-carbolines and tetrahydroisoquinolines: detection and function in mammals.

Authors:  H Rommelspacher; T May; R Susilo
Journal:  Planta Med       Date:  1991-10       Impact factor: 3.352

9.  Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450.

Authors:  S B Ross
Journal:  Pharmacol Toxicol       Date:  1991-04

Review 10.  MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Authors:  M Gerlach; P Riederer; H Przuntek; M B Youdim
Journal:  Eur J Pharmacol       Date:  1991-12-12       Impact factor: 4.432

View more
  2 in total

1.  Modulation of voltage-gated channel currents by harmaline and harmane.

Authors:  Frank Splettstoesser; Udo Bonnet; Martin Wiemann; Dieter Bingmann; Dietrich Büsselberg
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  5-HT, dopamine, norepinephrine, and related metabolites in brain of low alcohol drinking (LAD) rats shift after chronic intra-hippocampal infusion of harman.

Authors:  A Adell; R D Myers
Journal:  Neurochem Res       Date:  1995-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.